– the leading provider of online annual reports to individual and institutional investors.

Hemispherx Biopharma, Inc.

Hemispherx Biopharma, Inc., a specialty pharmaceutical company, engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders.

No investor fact sheets added yet
No responsibility reports added yet

Browse Reports